Efficacy and Safety of Sunitinib on Metastatic Renal Cell Carcinoma: A Single-Institution Experience

PURPOSE: We assessed the efficacy and safety of the tyrosine kinase inhibitor sunitinib in Korean patients with metastatic renal cell carcinoma (mRCC). MATERIALS AND METHODS: Between September 2007 and December 2009, all twenty-one patients who had mRCC with a clear-cell component were retrospective...

Descripción completa

Detalles Bibliográficos
Autores principales: Hwang, Eugene, Lee, Hyo Jin, Sul, Chong Koo, Lim, Jae Sung
Formato: Texto
Lenguaje:English
Publicado: The Korean Urological Association 2010
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2907492/
https://www.ncbi.nlm.nih.gov/pubmed/20664776
http://dx.doi.org/10.4111/kju.2010.51.7.450

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2907492/
https://www.ncbi.nlm.nih.gov/pubmed/20664776
http://dx.doi.org/10.4111/kju.2010.51.7.450

Ejemplares similares